Affordable Access

Publisher Website

Blood transfusion: the silent epidemic

Authors
Journal
The Annals of Thoracic Surgery
0003-4975
Publisher
Elsevier
Publication Date
Volume
72
Issue
5
Identifiers
DOI: 10.1016/s0003-4975(01)03259-3
Keywords
  • 25
Disciplines
  • Medicine

Abstract

Abstract Blood transfusion has been widely studied and the risk/benefit ratio remains unclear. Focus historically has been upon viral transmission, particularly hepatitis and HIV. Today, with advanced screening for these viruses, the risk for such transmission has become vanishingly small. Immunosuppression, with consequent postoperative bacterial infection and ABO incompatibility are now risks that physicians should consider as associated with allogeneic blood transfusion. Other inflammatory events, such as transfusion associated acute lung injury, also occur. The benefits of transfusion have never been well studied and there is scant literature on that area. Therefore, in an evidence-based medical practice the physician should regard transfusion with a skewed risk/benefit ratio. The following article examines that risk/benefit ratio in the post-AIDS era.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Blood transfusion: the silent epidemic.

on The Annals of Thoracic Surgery November 2001

Blood transfusion immunomodulation: the silent epi...

on Archives of pathology & labora... February 1998

The silent risks of blood transfusion.

on Current opinion in anaesthesio... October 2008
More articles like this..